Cellcept and Clindesse drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Clindesse (clindamycin phosphate). Common drug interactions include headache among females.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Clindesse. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Clindesse?

Clindesse has active ingredients of clindamycin phosphate. eHealthMe is studying from 202 Clindesse users. Check the latest studies of Clindesse.



On Jul, 13, 2026

11 people who take Cellcept and Clindesse together, and have interactions are studied.

Cellcept and Clindesse drug interactions.

What are the common drug interactions of Cellcept and Clindesse, by gender? *:

female:

  1. Headache (pain in head)
  2. Fall
  3. Diabetic blindness (blindness due to diabetes)
  4. Fatigue (feeling of tiredness)
  5. Feeling jittery
  6. Haemoglobin decreased
  7. Myasthenia gravis crisis (a paralysis of the respiratory muscles occurs)
  8. Pain
  9. Procedural nausea
  10. Procedural vomiting

male:

n/a

What are the common drug interactions of Cellcept and Clindesse, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Headache (pain in head)
  2. Urinary tract infection
  3. Procedural nausea
  4. Procedural vomiting
  5. Therapeutic response decreased (less preventive response)
  6. Chest discomfort
  7. Disease progression
  8. Dyspnoea (difficult or laboured respiration)
  9. Fall
  10. Foot fracture

60+:

n/a

What are the existing conditions these people have? *

  1. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 9 people, 81.82%
  2. Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 18.18%
  3. Chronic Renal Failure (kidney failure): 1 person, 9.09%
  4. Chronic Kidney Disease: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Clindesse?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Clindesse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clindesse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clindesse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and clindamycin phosphate (the active ingredients of Cellcept and Clindesse, respectively), and Cellcept and Clindesse (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: